VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
UAMYUnited States Antimony Corporation
$7.85$1.2B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

UAMY logoUnited States Antimony Corporation(UAMY)Earnings, Financials & Key Ratios

UAMY•NYSE
Price updated Jun 19, 2026
SectorBasic MaterialsIndustryIndustrial MaterialsSub-IndustrySpecialty and Advanced Materials
AboutUnited States Antimony Corporation produces and sells antimony, silver, gold, and zeolite products in the United States and Canada. The company's Antimony division offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. Its antimony oxide is also used as a color fastener in paints; as a catalyst for the production of polyester resins for fibers and films; as a catalyst for the production of polyethelene pthalate in plastic bottles; as a phosphorescent agent in fluorescent light bulbs; and as an opacifier for porcelains. In addition, this division offers sodium antimonite; and antimony metal for use in bearings, storage batteries, and ordnance; and precious metals. The company's Zeolite division provides zeolite deposits for soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition applications. Its zeolite products also have applications in catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, and floor cleaners, as well as carriers for insecticides, pesticides, and herbicides. United States Antimony Corporation was founded in 1968 and is based in Thompson Falls, Montana.Show more
  • Revenue$39M+162.8%
  • EBITDA-$8M-484.9%
  • Net Income-$4M-150.8%
  • EPS (Diluted)-0.04-120.0%
  • Gross Margin-4.35%-118.7%
  • EBITDA Margin-19.44%-122.5%
  • Operating Margin-22.61%-41.3%
  • Net Margin-11.05%+4.6%
  • ROE-5.12%+20.0%

UAMY Key Insights

United States Antimony Corporation (UAMY) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 49.6%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 13.9% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when UAMY posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

UAMY Price & Volume

United States Antimony Corporation (UAMY) stock price & volume — 10-year historical chart

Loading chart...

UAMY Growth Metrics

United States Antimony Corporation (UAMY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years11.59%
5 Years49.62%
3 Years52.61%
TTM94.17%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-1779.03%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-1071.84%

Return on Capital

10 Years-11.98%
5 Years-8.85%
3 Years-14.05%
Last Year-10.18%

UAMY Recent Earnings

United States Antimony Corporation (UAMY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (17%)●Beat Revenue 2/12 qtrs (29%)
Q2 2026Latest
May 14, 2026
Metric
Actual
Est
EPS
$0.01+50.0%
$0.02
Rev
$7M-54.2%
$15M
Q2 2026
Mar 19, 2026
Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$13M+2.1%
$13M
Q4 2025
Nov 12, 2025
Metric
Actual
Est
EPS
$0.04-300.0%
$0.02
Rev
$9M-40.6%
$15M
Q3 2025
Aug 12, 2025
Metric
Actual
Est
EPS
$0.00-85.7%
$0.01
Rev
$11M-17.0%
$13M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 14, 2026
$0.01vs $0.02+50.0%
$7Mvs $15M-54.2%
Q2 2026Mar 19, 2026
$0.01vs $0.01+0.0%
$13Mvs $13M+2.1%
Q4 2025Nov 12, 2025
$0.04vs $0.02-300.0%
$9Mvs $15M-40.6%
Q3 2025Aug 12, 2025
$0.00vs $0.01-85.7%
$11Mvs $13M-17.0%
Based on last 12 quarters of dataView full earnings history →

UAMY Peer Comparison

United States Antimony Corporation (UAMY) competitors in Specialty and Advanced Materials — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
USAS logoUSASAmericas Gold and Silver CorporationDirect Competitor1.43B5.36-16.2417.71%-36.33%-41.36%0.21
EXK logoEXKEndeavour Silver Corp.Direct Competitor2.55B8.61-20.02115.25%-3.48%-3.75%0.42
HL logoHLHecla Mining CompanyDirect Competitor10.7B15.9632.5753.03%35.55%22.55%0.12
CDE logoCDECoeur Mining, Inc.Direct Competitor11.4B17.5119.4696.41%31.15%15.17%0.11
MP logoMPMP Materials Corp.Product Competitor10.84B60.88-121.7635.12%-20.48%-3.49%0.44
NB logoNBNioCorp Developments Ltd.Product Competitor722.96M5.31-14.75-21.45%0.00
CHMG logoCHMGChemung Financial CorporationProduct Competitor341.44M70.9722.67-6.46%10.79%6.27%0.02
FCX logoFCXFreeport-McMoRan Inc.Supply Chain98.7B68.6845.181.12%10.34%8.91%0.37

Compare UAMY vs Peers

United States Antimony Corporation (UAMY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs USAS

Most directly comparable listed peer for UAMY.

Scale Benchmark

vs SCCO

Larger-name benchmark to compare UAMY against a more recognizable public peer.

Peer Set

Compare Top 5

vs USAS, EXK, HL, CDE

UAMY Income Statement

United States Antimony Corporation (UAMY) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
10.23M9.03M8.27M5.24M7.75M11.04M8.69M14.94M39.26M39.04M
Revenue Growth %
-13.96%-11.69%-8.48%-36.68%47.98%42.56%-21.29%71.84%162.81%94.17%
Cost of Goods Sold
9.95M9.03M9.08M5.03M6.91M9.05M12.04M11.47M40.96M36.31M
COGS % of Revenue
97.31%99.98%109.87%96.07%89.18%81.93%138.48%76.79%104.35%-
Gross Profit
275.46K▲ 0%
1.54K▼ 99.4%
-816.25K▼ 53000.3%
205.7K▲ 125.2%
838.61K▲ 307.7%
2M▲ 138.0%
-3.34M▼ 267.6%
3.47M▲ 203.7%
-1.71M▼ 149.2%
2.73M▲ 0%
Gross Margin %
2.69%0.02%-9.87%3.93%10.82%18.07%-38.48%23.21%-4.35%7%
Gross Profit Growth %
-48.67%-99.44%-53000.26%125.2%307.69%138.04%-267.56%203.65%-149.24%-
Operating Expenses
1.24M-545.49K2.94M3.51M1.5M1.65M3.72M5.86M7.17M19.07M
OpEx % of Revenue
12.07%-6.04%35.53%67.05%19.35%14.92%42.84%39.21%18.26%-
Selling, General & Admin
1.24M1.54M1.44M1.22M1.24M1.44M2.92M5.37M5.48M17.74M
SG&A % of Revenue
12.07%17%17.4%23.33%16.01%13.06%33.64%35.96%13.96%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
0-2.08M1.5M2.29M258.3K205.74K799.57K486.11K1.69M1.33M
Operating Income
-959.7K▲ 0%
547.04K▲ 157.0%
-3.75M▼ 786.2%
-3.3M▲ 12.0%
-660.26K▲ 80.0%
348.2K▲ 152.7%
-7.07M▼ 2130.1%
-2.39M▲ 66.2%
-8.88M▼ 271.3%
-16.34M▲ 0%
Operating Margin %
-9.38%6.05%-45.4%-63.12%-8.52%3.15%-81.32%-16%-22.61%-41.84%
Operating Income Growth %
-17.54%157%-786.18%11.96%80.02%152.74%-2130.13%66.18%-271.31%-
EBITDA
9.19K1.45M-2.86M-2.42M220.62K1.26M-6.11M-1.31M-7.63M-15.01M
EBITDA Margin %
0.09%16.07%-34.56%-46.2%2.85%11.38%-70.28%-8.74%-19.44%-38.44%
EBITDA Growth %
-94.98%15700.2%-296.83%15.35%109.12%469.94%-585.88%78.64%-484.86%-3034.12%
D&A (Non-Cash Add-back)
968.89K904.84K895.99K885.84K880.88K909.22K959.45K1.09M1.24M1.33M
EBIT
-1.03M640.86K-3.59M-3.27M-54.93K348.2K-6.85M-2.38M-8.88M-16.14M
Net Interest Income
-106.1K-99.97K-78.34K-17.99K-5.54K50.78K618.76K668.54K810.55K971.45K
Interest Income
873000065.92K618.76K668.54K810.55K971.45K
Interest Expense
106.97K99.97K78.34K17.99K5.54K15.14K0000
Other Income/Expense
-174.69K-6.14K80.79K17.94K599.79K96.53K720.71K660.41K4.54M155.41K
Pretax Income
-1.13M▲ 0%
540.89K▲ 147.7%
-3.67M▼ 779.0%
-3.29M▲ 10.5%
-60.47K▲ 98.2%
444.73K▲ 835.5%
-6.35M▼ 1527.4%
-1.73M▲ 72.7%
-4.34M▼ 150.8%
-16.18M▲ 0%
Pretax Margin %
-11.09%5.99%-44.42%-62.78%-0.78%4.03%-73.03%-11.58%-11.05%-41.44%
Income Tax
0-332.33K00016.07K0000
Effective Tax Rate %
0%-61.44%0%0%0%3.61%0%0%0%0%
Net Income
-1.13M▲ 0%
873.23K▲ 177.0%
-3.67M▼ 520.6%
-3.29M▲ 10.5%
-60.47K▲ 98.2%
428.66K▲ 808.9%
-6.35M▼ 1581.0%
-1.73M▲ 72.7%
-4.34M▼ 150.8%
-16.18M▲ 0%
Net Margin %
-11.09%9.67%-44.42%-62.78%-0.78%3.88%-73.03%-11.58%-11.05%-41.44%
Net Income Growth %
13.35%176.98%-520.61%10.51%98.16%808.89%-1580.96%72.74%-150.78%-1779.03%
Net Income (Continuing)
-1.13M873.23K-3.67M-3.29M-60.47K428.66K-6.35M-1.73M-4.34M-16.18M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.02▲ 0%
0.01▲ 176.2%
-0.06▼ 541.4%
-0.05▲ 18.6%
-0.00▲ 97.6%
0.00▲ 427.3%
-0.06▼ 1741.7%
-0.02▲ 72.9%
-0.04▼ 120.0%
-0.11▲ 0%
EPS Growth %
14.29%176.19%-541.41%18.58%97.61%--72.93%-120%-1071.84%
EPS (Basic)
-0.020.01-0.06-0.05-0.000.00-0.06-0.02-0.04-
Diluted Shares Outstanding
67.41M68.1M69M72.51M102.84M106.29M107.55M108.59M123.64M141.61M
Basic Shares Outstanding
67.41M67.98M69M72.51M102.84M106.29M107.55M108.59M123.64M141.61M
Dividend Payout Ratio
----------

UAMY Balance Sheet

United States Antimony Corporation (UAMY) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
1.56M1.9M1.28M1.81M23.57M21.62M14.08M20.68M54.74M48.41M
Cash & Short-Term Investments
27.99K56.65K369.06K919.31K21.62M19.32M11.97M18.17M30.49M3.22M
Cash Only
27.99K56.65K115.51K665.1K21.36M19.06M11.9M18.17M30.49M3.22M
Short-Term Investments
00253.55K254.21K259.21K259.86K72.9K000
Accounts Receivable
362.58K838.39K284.45K238.63K891.31K784.46K625.26K1.16M4.21M2.51M
Days Sales Outstanding
12.9433.8712.5616.6441.9925.9226.2528.2639.1726.1
Inventory
914.71K755.26K626.24K650.21K1.06M1.38M1.39M1.25M12.52M22.03M
Days Inventory Outstanding
33.5430.5225.1647.1855.7655.4742.0339.64111.57125.09
Other Current Assets
4.7K-252.95K00000104.16K7.51M20.65M
Total Non-Current Assets
15.57M15.65M12.41M11.49M11.43M13.08M14.02M13.96M99.18M99.64M
Property, Plant & Equipment
15.13M15.23M12.19M11.23M11.13M12.13M13.45M13.46M42.42M46.71M
Fixed Asset Turnover
0.68x0.59x0.68x0.47x0.70x0.91x0.65x1.11x0.93x1.14x
Goodwill
0000000000
Intangible Assets
0000000000
Long-Term Investments
057.25K057.27K00098.78K40.49M79.92M
Other Non-Current Assets
436.09K369.45K227.37K208.47K300K954.97K564.3K408.52K16.27M16.5M
Total Assets
17.13M▲ 0%
17.56M▲ 2.5%
13.69M▼ 22.0%
13.3M▼ 2.9%
35M▲ 163.2%
34.7M▼ 0.9%
28.09M▼ 19.0%
34.64M▲ 23.3%
153.93M▲ 344.3%
148.05M▲ 0%
Asset Turnover
0.60x0.51x0.60x0.39x0.22x0.32x0.31x0.43x0.26x0.36x
Asset Growth %
-3.57%2.49%-22%-2.88%163.19%-0.86%-19.04%23.31%344.32%851.84%
Total Current Liabilities
3.93M3.52M3.98M4.48M2.07M2.22M897.46K4.01M10.18M13.37M
Accounts Payable
1.78M1.94M2.33M1.88M1.39M628.8K456.94K1.55M6.92M9.67M
Days Payables Outstanding
65.3578.5193.58136.273.2125.3613.8549.1861.766.75
Short-Term Debt
739.55K889.38K253.4K152.12K13.23K94.15K28.44K758.81K171.04K165.62K
Deferred Revenue (Current)
60.05K32.4K0756.15K000000
Other Current Liabilities
504.91K110.09K598.04K1.06M0787.73K0-626.56K3.08M3.53M
Current Ratio
0.40x0.54x0.32x0.40x11.38x9.74x15.68x5.16x5.38x3.62x
Quick Ratio
0.16x0.33x0.16x0.26x10.87x9.12x14.14x4.85x4.15x1.97x
Cash Conversion Cycle
-18.88-14.12-55.86-72.3824.5456.0354.4318.7189.0584.44
Total Non-Current Liabilities
2.82M2.61M1.25M1.64M563.07K611.33K1.68M2.04M2.79M2.79M
Long-Term Debt
1.24M1.03M76.76K477.7K201.92K217.85K0195.43K14K10.75K
Capital Lease Obligations
0000000129.01K0125.02K
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
1.58M1.59M1.17M1.16M361.15K393.47K1.68M1.71M2.78M2.78M
Total Liabilities
6.75M6.13M5.23M6.11M2.63M2.83M2.57M6.04M12.97M16.15M
Total Debt
1.98M1.92M330.16K629.83K215.15K312K28.44K1.71M185.05K176.36K
Net Debt
1.95M1.86M214.66K-35.28K-21.15M-18.75M-11.87M-16.46M-30.31M-3.04M
Debt / Equity
0.19x0.17x0.04x0.09x0.01x0.01x0.00x0.06x0.00x0.00x
Debt / EBITDA
215.33x1.32x--0.98x0.25x----0.01x
Net Debt / EBITDA
212.29x1.28x---95.86x-14.91x---0.20x
Interest Coverage
-9.60x6.41x-45.88x-181.69x-9.92x23.00x----
Total Equity
10.38M▲ 0%
11.42M▲ 10.1%
8.47M▼ 25.9%
7.19M▼ 15.1%
32.37M▲ 350.4%
31.87M▼ 1.5%
25.52M▼ 19.9%
28.6M▲ 12.1%
140.96M▲ 392.8%
131.89M▲ 0%
Equity Growth %
-8.51%10.1%-25.89%-15.13%350.42%-1.54%-19.92%12.07%392.84%929.01%
Book Value per Share
0.150.170.120.100.310.300.240.261.140.93
Total Shareholders' Equity
10.38M11.42M8.47M7.19M32.37M31.87M25.52M28.6M140.96M131.89M
Common Stock
674.88K682.27K696.61K759.5K1.06M1.06M1.08M1.13M1.4M1.44M
Retained Earnings
-26.56M-25.69M-29.36M-32.65M-32.71M-33.07M-39.42M-41.15M-45.49M-56.78M
Treasury Stock
00000-202.98K00-574.15K0
Accumulated OCI
-8.71M-9.62M00000000
Minority Interest
0000000000

UAMY Cash Flow Statement

United States Antimony Corporation (UAMY) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
716.71K-656.63K-11.36K-1.31M-2.43M-249.28K-4.75M2.22M-9.69M-20.02M
Operating CF Margin %
7.01%-7.27%-0.14%-24.94%-31.38%-2.26%-54.64%14.86%-24.69%-
Operating CF Growth %
68.31%-191.62%98.27%-11398.58%-86.23%89.75%-1805.52%146.74%-536.47%-2242.47%
Net Income
-1.13M873.23K-3.67M-3.29M-60.47K428.66K-6.35M-1.73M-4.34M-16.18M
Depreciation & Amortization
968.89K904.84K895.99K885.84K880.88K909.22K959.45K1.09M1.17M1.37M
Stock-Based Compensation
175K175K136K047.5K61.46K0568.59K7.08M2.98M
Deferred Taxes
0-875K0000687.53K000
Other Non-Cash Items
306.11K-1.24M1.62M431.8K-475.63K412.86K2.56M195.58K-1.58M10.9M
Working Capital Changes
576.1K-499.18K1.01M663.5K-2.82M-2.06M-2.61M2.1M-12.02M-19.09M
Change in Receivables
189.54K-75.81K353.27K7.46K-686.93K-607.45K-80.57K-270.26K-3.1M-802.73K
Change in Inventory
-59.07K159.45K112.62K-23.97K-405.21K-596.79K-2.08M74.74K-12.2M-19.12M
Change in Payables
479.11K-350.04K402.66K-452.1K-491.12K-756.95K-171.87K1.09M3.4M-479.24K
Cash from Investing
-365.54K900.88K-392.93K-243.09K-653.13K-1.79M-1.34M-42.07K-87.4M-99.12M
Capital Expenditures
-365.54K-899.12K-792.92K-243.09K-648.13K-1.73M-1.53M-430.6K-27.81M-39.53M
CapEx % of Revenue
3.57%9.95%9.59%4.64%8.37%15.63%17.58%2.88%70.84%101.24%
Acquisitions
01.8M000000010.12K
Investments
----------
Other Investing
01.8M400K0000315.63K-2.49M-12.39M
Cash from Financing
-333.23K-221.69K463.15K2.1M23.78M-267.73K-1.07M4.14M109.48M103.68M
Debt Issued (Net)
-211.53K-239.92K-114.53K299.66K-186.43K-64.75K-283.56K-103.49K-132.25K-133.41K
Equity Issued (Net)
00404.2K1.81M23.34M-202.98K02.76M109.61M102.34M
Dividends Paid
000000-787.73K000
Share Repurchases
00000-202.98K00-449.48K-5.43M
Other Financing
-121.7K18.23K173.49K-14.37K626.8K001.48M01.47M
Net Change in Cash
17.93K▲ 0%
22.57K▲ 25.9%
58.87K▲ 160.9%
549.61K▲ 833.6%
20.7M▲ 3665.9%
-2.3M▼ 111.1%
-7.16M▼ 211.1%
6.32M▲ 188.2%
12.39M▲ 96.1%
-15.49M▲ 0%
Free Cash Flow
351.16K▲ 0%
-1.56M▼ 543.0%
-804.28K▲ 48.3%
-1.55M▼ 92.6%
-3.08M▼ 98.8%
-1.98M▲ 35.8%
-6.28M▼ 217.8%
1.79M▲ 128.5%
-37.5M▼ 2195.3%
-59.55M▲ 0%
FCF Margin %
3.43%-17.22%-9.73%-29.58%-39.75%-17.89%-72.23%11.98%-95.52%-152.53%
FCF Growth %
306.56%-543.03%48.3%-92.56%-98.84%35.85%-217.8%128.5%-2195.29%-7211.9%
FCF per Share
0.01-0.02-0.01-0.02-0.03-0.02-0.060.02-0.30-0.42
FCF Conversion (FCF/Net Income)
-0.63x-0.75x0.00x0.40x40.21x-0.58x0.75x-1.28x2.23x3.68x
Interest Paid
0024.23K17.99K5.54K15.14K10.52K8.87K02.31K
Taxes Paid
0000000000

UAMY Key Ratios

United States Antimony Corporation (UAMY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-10.45%8.01%-36.93%-41.99%-0.31%1.33%-22.12%-6.39%-5.12%-16.94%
Return on Invested Capital (ROIC)
-5.6%3.2%-25.63%-31.31%-5.39%2.15%-39.61%-13.91%-10.85%-15.04%
Gross Margin
2.69%0.02%-9.87%3.93%10.82%18.07%-38.48%23.21%-4.35%7%
Net Margin
-11.09%9.67%-44.42%-62.78%-0.78%3.88%-73.03%-11.58%-11.05%-41.44%
Debt / Equity
0.19x0.17x0.04x0.09x0.01x0.01x0.00x0.06x0.00x0.00x
Interest Coverage
-9.60x6.41x-45.88x-181.69x-9.92x23.00x----
FCF Conversion
-0.63x-0.75x0.00x0.40x40.21x-0.58x0.75x-1.28x2.23x3.68x
Revenue Growth
-13.96%-11.69%-8.48%-36.68%47.98%42.56%-21.29%71.84%162.81%94.17%
Related:UAMY Dividend History·UAMY Revenue History·UAMY Price History·UAMY P/E History·UAMY Financial Ratios·UAMY Institutional Holders

UAMY SEC Filings & Documents

United States Antimony Corporation (UAMY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 14, 2026·SEC

Material company update

May 6, 2026·SEC

10-K Annual Reports

1
FY 2026

Mar 19, 2026·SEC

10-Q Quarterly Reports

4
FY 2026

May 14, 2026·SEC

FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 12, 2025·SEC

UAMY Frequently Asked Questions

United States Antimony Corporation (UAMY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

United States Antimony Corporation (UAMY) reported $39.0M in revenue for fiscal year 2025. This represents a 679% increase from $5.0M in 1996.

United States Antimony Corporation (UAMY) grew revenue by 162.8% over the past year. This is strong growth.

United States Antimony Corporation (UAMY) reported a net loss of $16.2M for fiscal year 2025.

Dividend & Returns

United States Antimony Corporation (UAMY) has a return on equity (ROE) of -5.1%. Negative ROE indicates the company is unprofitable.

United States Antimony Corporation (UAMY) had negative free cash flow of $59.5M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in UAMY back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in UAMY be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →